Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

9477	Companies
185475	Keywords
117817	Articles
99317	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 04/24/2025 at 07:16, 7 months 11 days ago

Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025
Heidelberg Pharma AG reports positive results for ATAC candidates HDP-101 and HDP-102 in Q1 2025, extends cash reach through financing activities, and progresses towards market approval for TLX250-CDx

HDP-101 Heidelberg Pharma AG TLX250-CDx ATAC Candidates HDP-102
BRIEF

published on 03/26/2025 at 09:28, 8 months 10 days ago

Heidelberg Pharma présentera ses innovations ADC à l'AACR 2025

Heidelberg Pharma HDP-201 Technologie ADC AACR 2025 Inhibiteurs De NAMPT
BRIEF

published on 03/26/2025 at 09:28, 8 months 10 days ago

Heidelberg Pharma to Showcase ADC Innovations at AACR 2025

Heidelberg Pharma ADC Technology HDP-201 AACR 2025 NAMPT Inhibitors
PRESS RELEASE

published on 03/26/2025 at 09:23, 8 months 10 days ago

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
Heidelberg Pharma AG to present latest ADC research results and advancements at AACR Annual Meeting 2025, showcasing Exatecan-based and Amanitin-based ADC technology platforms

Heidelberg Pharma ADC AACR Annual Meeting 2025 Exatecan-based ADC Amanitin-based ADC
BRIEF

published on 03/21/2025 at 07:12, 8 months 15 days ago

Heidelberg Pharma Reports 2024 Financial Results and Clinical Progress

Clinical Trials Heidelberg Pharma ADC Technology Multiple Myeloma 2024 Financial Results
BRIEF

published on 03/21/2025 at 07:12, 8 months 15 days ago

Heidelberg Pharma publie ses résultats financiers et ses progrès cliniques pour 2024

Essais Cliniques Heidelberg Pharma Myélome Multiple Résultats Financiers 2024 Technologie ADC
PRESS RELEASE

published on 03/21/2025 at 07:07, 8 months 15 days ago

Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
Heidelberg Pharma AG reports successful business performance in 2024 with improved financial figures including clinical trial results for HDP-101 in multiple myeloma and upcoming study for HDP-102. Financial outlook and strategy for 2025 highlighted

Financial Results Clinical Trial Heidelberg Pharma AG 2025 Outlook ATAC Technology
BRIEF

published on 03/13/2025 at 07:35, 8 months 23 days ago

Heidelberg Pharma Adjusts Royalty Financing with HealthCare Royalty

FDA Approval Heidelberg Pharma HealthCare Royalty Royalty Financing TLX250-CDx
BRIEF

published on 03/13/2025 at 07:35, 8 months 23 days ago

Heidelberg Pharma ajuste son financement par redevances avec HealthCare Royalty

Heidelberg Pharma Financement Des Redevances Approbation De La FDA TLX250-CDx Redevance Des Soins De Santé
PRESS RELEASE

published on 03/13/2025 at 07:30, 8 months 23 days ago

Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Heidelberg Pharma and HealthCare Royalty amend royalty financing agreement, providing for USD 20 million payment and extending cash runway into 2027

Amendment Heidelberg Pharma HealthCare Royalty Royalty Financing Cash Runway

Accesswire

Published on 12/05/2025 at 14:00, 1 hour 3 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 3 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 28 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours 33 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 14 hours 3 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 41 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 46 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 53 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 18 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 2 hours 3 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 13:58, 1 hour 5 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 18 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 18 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 6 hours 21 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 20 hours 48 minutes ago

Résiliation d'une convention conclue entre actionnaires

View all LES ECHOS COMFI WIRE